SLC4A7 and triple-negative breast carcinoma: To test the cellular influences of the inhibitory anti-NBCn1 antibodies in greater detail, we next studied effects of the 5H2.1 antibody on the human CAL51 cell line, which is derived from a patient with metastatic triple-negative breast cancer [39, 40].